Pancreatic Ductal Adenocarcinoma — Trials

Pancreatic Ductal Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

414 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 208
Recruiting: 129
Ph III recruiting: 13
Growth YoY: +56.5%
Industry share: 50%
Top sponsor: Revolution Medicines, Inc.
Termination share: 46.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (56)

clinicaltrialsPublishedShowing 401–414 of 414 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03316326	S-1, Irinotecan, and Oxaliplatin in Locally-Advanced Pancreatic Cancer	unknown	Phase 2	35	National Taiwan University HospitalOTHER	0	Oct 20, 2017	clinicaltrials
NCT01897415	Autologous Redirected RNA Meso CAR T Cells for Pancreatic Cancer	completed	Phase 1	16	University of PennsylvaniaOTHER	1	Sep 19, 2017	clinicaltrials
NCT02607826